Literature DB >> 14736853

Role of matrix metalloproteinases in delayed neuronal damage after transient global cerebral ischemia.

Seong-Ryong Lee1, Kiyoshi Tsuji, Sun-Ryung Lee, Eng H Lo.   

Abstract

Mechanisms of selective neuronal death in the hippocampus after global cerebral ischemia remain to be clarified. Here, we explored a possible role for matrix metalloproteinases (MMPs) in this phenomenon. Although many studies have demonstrated detrimental roles for the gelatinase MMP-9 in focal cerebral ischemia, how dysregulated MMP proteolysis influences global cerebral ischemia is less well understood. In this study, CD-1 mice were subjected to transient global ischemia. Transient occlusions of common carotid arteries for periods between 20 and 40 min led to increasing hippocampal neuronal death after 3 d. Gel zymography showed elevations in gelatinase (MMP-2 and MMP-9) activity. In situ zymography showed that gelatinase activity was mostly colocalized with neuron-specific nuclear protein-stained pyramidal neurons. Mice treated with the broad-spectrum metalloproteinase inhibitor BB-94 (50 mg/kg, i.p.) showed reduced hippocampal gelatinase activity after transient global cerebral ischemia and suffered significantly reduced hippocampal neuronal damage compared with vehicle-treated controls (p < 0.01). Additionally, hippocampal gelatinase activity and neuronal damage after transient global ischemia were also significantly reduced in MMP-9 knock-out mice compared with wild-type mice (p < 0.05). These data indicate a potential deleterious role for MMP-9 in the pathogenesis of delayed neuronal damage in the hippocampus after global cerebral ischemia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14736853      PMCID: PMC6729252          DOI: 10.1523/JNEUROSCI.4243-03.2004

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  71 in total

1.  Matrix metalloproteinase-9 and -2 expression in the olfactory bulb following methyl bromide gas exposure.

Authors:  Stephen R Bakos; James E Schwob; Richard M Costanzo
Journal:  Chem Senses       Date:  2010-06-07       Impact factor: 3.160

2.  Peak in matrix metaloproteinases-2 levels observed during recovery from olfactory nerve injury.

Authors:  Richard M Costanzo; Lisa A Perrino
Journal:  Neuroreport       Date:  2008-02-12       Impact factor: 1.837

Review 3.  Neurovascular matrix metalloproteinases and the blood-brain barrier.

Authors:  Ji Hae Seo; Shuzhen Guo; Josephine Lok; Deepti Navaratna; Michael J Whalen; Kyu-Won Kim; Eng H Lo
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

4.  Metalloprotein-inhibitor binding: human carbonic anhydrase II as a model for probing metal-ligand interactions in a metalloprotein active site.

Authors:  David P Martin; Zachary S Hann; Seth M Cohen
Journal:  Inorg Chem       Date:  2013-05-24       Impact factor: 5.165

Review 5.  Brain vulnerability and viability after ischaemia.

Authors:  Stefano G Daniele; Georg Trummer; Konstantin A Hossmann; Zvonimir Vrselja; Christoph Benk; Kevin T Gobeske; Domagoj Damjanovic; David Andrijevic; Jan-Steffen Pooth; David Dellal; Friedhelm Beyersdorf; Nenad Sestan
Journal:  Nat Rev Neurosci       Date:  2021-07-21       Impact factor: 34.870

6.  Diffusion-weighted magnetic resonance imaging reversal by gene knockdown of matrix metalloproteinase-9 activities in live animal brains.

Authors:  Christina H Liu; Zerong You; Charng-Ming Liu; Young R Kim; Michael J Whalen; Bruce R Rosen; Philip K Liu
Journal:  J Neurosci       Date:  2009-03-18       Impact factor: 6.167

7.  MMPs initiate Schwann cell-mediated MBP degradation and mechanical nociception after nerve damage.

Authors:  Hideo Kobayashi; Sharmila Chattopadhyay; Kinshi Kato; Jennifer Dolkas; Shin-Ichi Kikuchi; Robert R Myers; Veronica I Shubayev
Journal:  Mol Cell Neurosci       Date:  2008-09-05       Impact factor: 4.314

8.  Endogenous matrix metalloproteinase (MMP)-3 and MMP-9 promote the differentiation and migration of adult neural progenitor cells in response to chemokines.

Authors:  Basam Z Barkho; Ari E Munoz; Xuekun Li; Lu Li; Lee Anna Cunningham; Xinyu Zhao
Journal:  Stem Cells       Date:  2008-09-25       Impact factor: 6.277

9.  Combination therapy of 17beta-estradiol and recombinant tissue plasminogen activator for experimental ischemic stroke.

Authors:  Ran Liu; Qing Liu; Shaoqing He; James W Simpkins; Shao-Hua Yang
Journal:  J Pharmacol Exp Ther       Date:  2009-12-01       Impact factor: 4.030

10.  Course of matrix metalloproteinase-9 isoforms after the administration of uric acid in patients with acute stroke: a proof-of-concept study.

Authors:  Sergio Amaro; Víctor Obach; Alvaro Cervera; Xabier Urra; Manuel Gómez-Choco; Anna M Planas; Angel Chamorro
Journal:  J Neurol       Date:  2009-04-27       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.